lobbying_activities: 1584532

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1584532	629b4407-1af9-47d0-8540-507e26a4ce87	Q3	PHARMAVITE LLC	286074	PHARMAVITE LLC	2014	third_quarter	FOO	Discussed FDA's NDI guidance document issued 2011 and need to have FDA issue revised draft. Support for both HR 4771 and SB 2012. Support for full enforcement of DSHEA. Dept of Commerce meeting - discuss regulatory hurdles relative to marketing dietary supplement products in China.	Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2014-10-13T14:45:08.020000-04:00